Covid-19 Recovery Study

Covid-19 Recovery Study

There is currently no known treatment for Covid-19. So far, over 30,000 people are taking part in a range of NIHR supported COVID-19 research studies across the UK.

This study aims to compare several different treatments given in addition to the usual care that may be useful for patients with COVID-19.  Although these treatments show promise, nobody knows if any of them will turn out to be more effective in helping patients recover than the usual standard of care.

Dr Nick Maskell talks about the Recovery study at North Bristol NHS Trust.

 

 

The Results

Peter Horby, Professor of Emerging Infectious Diseases in the Nuffield Department of Medicine, University of Oxford, and one of the Chief Investigators for the trial, said: ‘Dexamethasone is the first drug to be shown to improve survival in COVID-19. This is an extremely welcome result. The survival benefit is clear and large in those patients who are sick enough to require oxygen treatment, so dexamethasone should now become standard of care in these patients. Dexamethasone is inexpensive, on the shelf, and can be used immediately to save lives worldwide.’
To find out more about the results of this study visit
https://www.recoverytrial.net/news/low-cost-dexamethasone-reduces-death-...
Thank you to all of our research teams who are making such a different to people’s lives and also Southmead Hospital charity which is raising funds for covid-19 research